LifeStance to Sell 22.25M Shares
LifeStance Health Group appointed Barclays Capital as the underwriter for an offering of 22,250,000 shares of common stock. The filing outlines a concurrent 2,000,000 share repurchase agreement.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day